These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26753686)

  • 41. Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.
    Lin X; Peng Z; Su C
    Int J Mol Sci; 2015 May; 16(5):10888-906. PubMed ID: 25984608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticancer Properties of Psidium guajava - a Mini-Review.
    Correa MG; Couto JS; Teodoro AJ
    Asian Pac J Cancer Prev; 2016; 17(9):4199-4204. PubMed ID: 27797217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
    Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
    Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
    [No Abstract]   [Full Text] [Related]  

  • 45. Plants and their active compounds: natural molecules to target angiogenesis.
    Lu K; Bhat M; Basu S
    Angiogenesis; 2016 Jul; 19(3):287-95. PubMed ID: 27154020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenesis: from plants to blood vessels.
    Fan TP; Yeh JC; Leung KW; Yue PY; Wong RN
    Trends Pharmacol Sci; 2006 Jun; 27(6):297-309. PubMed ID: 16697473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineoplastic potential of medicinal plants.
    Shynu M; Gupta PK; Saini M
    Recent Pat Biotechnol; 2011 Aug; 5(2):85-94. PubMed ID: 21707529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
    Lee JS; Shukla S; Kim JA; Kim M
    PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Zidan J; Bar Sela G
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):588-97. PubMed ID: 21986478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-angiogenesis for cancer: Current status and prospects.
    Russo M; Giavazzi R
    Thromb Res; 2018 Apr; 164 Suppl 1():S3-S6. PubMed ID: 29703482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer.
    Bertolini F; Marighetti P; Martin-Padura I; Mancuso P; Hu-Lowe DD; Shaked Y; D'Onofrio A
    Drug Discov Today; 2011 Dec; 16(23-24):1052-60. PubMed ID: 21875682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alstonia scholaris Linn R Br in the treatment and prevention of cancer: past, present, and future.
    Manjeshwar Shrinath Baliga
    Integr Cancer Ther; 2010 Sep; 9(3):261-9. PubMed ID: 20702494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment.
    Forouzanfar F; Mousavi SH
    Curr Drug Targets; 2020; 21(12):1237-1249. PubMed ID: 32364070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs.
    Mbele M; Hull R; Dlamini Z
    Exp Mol Pathol; 2017 Oct; 103(2):121-134. PubMed ID: 28797846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century.
    Saeidnia S; Abdollahi M
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):49-63. PubMed ID: 23680455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A; Aigner A; Bakowsky U
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiogenesis inhibitors. New anticancer strategy.
    Zgodziński W; Wallner G; Dabrowski A
    Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.